Investigational Site Number :1560028

Tianjin 300121

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Chronic Kidney Diseases, Heart Failure, Type 2 Diabetes Mellitus

Studies at this site

• Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer — Stopped early
• Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk — Stopped early